11:57 EDT Cel Sci trading halted, news pending
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CVM:
- CEL-SCI teams with Saudi Arabia pharmaceutical, healthcare company for Multikine
- Biotech Alert: Searches spiking for these stocks today
- CEL-SCI 2M share Spot Secondary priced at $2.50
- CEL-SCI announces common stock offering, no amount given
- CEL-SCI completes Breakthrough Medicine Designation application for Multikine